Total Payments
$5,497
2024 Payments
$830.90
Companies
25
Transactions
108
Medicare Patients
8,055
Medicare Billing
$878,994
Payment Breakdown by Category
Food & Beverage$5,479 (99.7%)
Education$17.84 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,479 | 107 | 99.7% |
| Education | $17.84 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LENSAR, Inc. | $1,244 | 1 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $667.91 | 8 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $477.84 | 31 | $0 (2023) |
| Allergan, Inc. | $477.53 | 18 | $0 (2020) |
| BIOTISSUE HOLDINGS INC. | $457.30 | 3 | $0 (2024) |
| Alcon Vision LLC | $448.32 | 6 | $0 (2024) |
| ABBVIE INC. | $270.02 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $234.75 | 9 | $0 (2020) |
| Ivantis, Inc | $207.63 | 2 | $0 (2021) |
| Sight Sciences, Inc. | $149.64 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $830.90 | 8 | BIOTISSUE HOLDINGS INC. ($285.72) |
| 2023 | $693.63 | 10 | BIOTISSUE HOLDINGS, INC. ($171.58) |
| 2022 | $339.33 | 15 | Novartis Pharmaceuticals Corporation ($147.70) |
| 2021 | $1,645 | 14 | LENSAR, Inc. ($1,244) |
| 2020 | $382.84 | 10 | Aerie Pharmaceuticals, Inc. ($249.05) |
| 2019 | $683.18 | 19 | Allergan Inc. ($175.72) |
| 2018 | $706.57 | 22 | Aerie Pharmaceuticals, Inc. ($252.02) |
| 2017 | $216.11 | 10 | Allergan Inc. ($94.38) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $142.86 | General |
| 10/17/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $133.25 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $142.86 | General |
| 07/24/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $106.65 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $146.56 | General |
| Category: EYE CARE | ||||||
| 11/14/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $27.39 | General |
| Category: Ophthalmology | ||||||
| 11/03/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $121.90 | General |
| Category: Ophthalmology | ||||||
| 09/29/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/16/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Ophthalmology | ||||||
| 08/14/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Education | In-kind items and services | $17.84 | General |
| Category: Ophthalmology | ||||||
| 07/11/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $115.11 | General |
| Category: DRY EYE | ||||||
| 06/05/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Ophthalmology | ||||||
| 04/17/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $171.58 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 01/18/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Ophthalmology | ||||||
| 01/10/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $149.64 | General |
| Category: Ophthalmology | ||||||
| 12/08/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Ophthalmology | ||||||
| 12/05/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Ophthalmology | ||||||
| 11/18/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/28/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/04/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2022 | Alcon Vision LLC | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Glaucoma | ||||||
| 09/15/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,146 | 2,860 | $1.3M | $231,204 |
| 2022 | 22 | 2,590 | 3,410 | $1.4M | $259,789 |
| 2021 | 16 | 1,704 | 2,390 | $1.1M | $201,703 |
| 2020 | 20 | 1,615 | 2,264 | $955,498 | $186,299 |
Total Patients
8,055
Total Services
10,924
Medicare Billing
$878,994
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 401 | 507 | $152,000 | $51,102 | 33.6% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 48 | 85 | $297,500 | $40,230 | 13.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 239 | 350 | $69,950 | $26,375 | 37.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 69 | 237 | $237,000 | $23,198 | 9.8% |
| 92250 | Photography of the retina | Office | 2023 | 397 | 414 | $61,926 | $13,170 | 21.3% |
| 92134 | Imaging of retina | Office | 2023 | 241 | 346 | $103,262 | $12,235 | 11.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 64 | 204 | $30,600 | $11,131 | 36.4% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 16 | 21 | $73,500 | $10,509 | 14.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 20 | 31 | $77,500 | $9,446 | 12.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $21,760 | $9,189 | 42.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 153 | 158 | $31,600 | $8,063 | 25.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 44 | 44 | $13,200 | $4,956 | 37.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 31 | 31 | $20,150 | $3,489 | 17.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 117 | 119 | $35,700 | $3,409 | 9.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 134 | 136 | $13,600 | $1,724 | 12.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 20 | 20 | $6,000 | $842.87 | 14.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 16 | $5,600 | $703.03 | 12.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 27 | 29 | $2,900 | $629.00 | 21.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 18 | 18 | $1,800 | $403.74 | 22.4% |
| 92285 | Photography of content of eyes | Office | 2023 | 12 | 12 | $1,200 | $255.52 | 21.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 14 | 14 | $840.00 | $143.43 | 17.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 401 | 513 | $153,500 | $53,049 | 34.6% |
| 67210 | Destruction of growth of retina using a laser | Office | 2022 | 50 | 83 | $290,500 | $39,834 | 13.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 325 | 494 | $98,800 | $37,352 | 37.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 63 | 222 | $222,000 | $22,666 | 10.2% |
About Dr. Jonathan Sheindlin, M.D
Dr. Jonathan Sheindlin, M.D is a Specialist healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598861668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Sheindlin, M.D has received a total of $5,497 in payments from pharmaceutical and medical device companies, with $830.90 received in 2024. These payments were reported across 108 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,479).
As a Medicare-enrolled provider, Sheindlin has provided services to 8,055 Medicare beneficiaries, totaling 10,924 services with total Medicare billing of $878,994. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Ophthalmology, Retina Specialist
- Location Bronx, NY
- Active Since 09/16/2006
- Last Updated 02/22/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598861668
Products in Payments
- LENSAR LASER SYSTEM (Device) $1,244
- XIIDRA (Drug) $506.49
- Rhopressa (Drug) $394.82
- Rocklatan (Drug) $246.90
- rocklatan (Drug) $176.15
- LUMIGAN (Drug) $173.41
- PROKERA (Device) $171.58
- OMNI SURGICAL SYSTEM (Device) $149.64
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $146.56
- DURYSTA (Drug) $142.21
- Clareon (Device) $133.25
- Hydrus Microstent (Device) $128.72
- rhopressa (Drug) $124.69
- EYLEA (Biological) $120.87
- XEN (Device) $117.74
- TYRVAYA (Drug) $115.11
- EYLEA AFLIBERCEPT INJECTION (Biological) $113.88
- enVista MX60 IOL (Device) $106.65
- DEXTENZA (Drug) $95.18
- RESTASIS (Drug) $94.38
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bronx
Randall Berliner, Md, MD
Specialist — Payments: $203,928
Specialist $203,928
Mahmood Kazmi
Specialist — Payments: $186,504
Specialist $186,504
Dr. Peter Barland, M.d, M.D
Specialist — Payments: $85,232
Specialist $85,232
Dr. Evan Garfein, Md, MD
Specialist — Payments: $75,467
Specialist $75,467
Dr. Ghazanfar Abdullah, Md, MD
Specialist — Payments: $42,101
Specialist $42,101
Karen Hennessey, M.d, M.D
Specialist — Payments: $30,727
Specialist $30,727